Back to All Posts
POST

HBOT for IVF and Fertility: How Hyperbaric Oxygen Therapy Supports Conception in Los Angeles

hbot-ivf-fertility-hyperbaric-oxygen-therapy-los-angeles
July 11, 2026

TLDR

Hyperbaric oxygen therapy (HBOT) is an evidence-backed adjunct treatment that improves IVF outcomes by increasing oxygen delivery to the uterus and ovaries, thickening the endometrial lining, reducing oxidative stress, and improving egg and sperm quality. At OxygenWell in Sherman Oaks and Calabasas, CA, patients begin a personalized fertility HBOT protocol 6–8 weeks before embryo transfer for optimal results.

Table of Contents

What Is HBOT and How Does It Support Fertility?

Hyperbaric oxygen therapy (HBOT) delivers 100% medical-grade oxygen inside a pressurized chamber at 1.5–2.0 ATA. At this pressure, oxygen dissolves directly into the plasma — reaching tissues that normal circulation cannot adequately supply. For fertility patients, this means the ovaries, uterus, endometrium, and pelvic reproductive tissues receive a level of oxygenation 10–15 times higher than breathing room air.

The mechanisms through which HBOT supports fertility are well-documented in peer-reviewed literature:

  • Angiogenesis: HBOT stimulates the growth of new blood vessels (VEGF upregulation), improving circulation to the uterine lining and ovarian tissue. [PubMed, 2023]
  • Mitochondrial support: Elevated oxygen boosts ATP production in egg and sperm cells, directly improving cellular energy and quality.
  • Oxidative stress reduction: HBOT activates antioxidant pathways (SOD, glutathione), protecting reproductive cells from oxidative damage — a primary driver of poor egg quality and implantation failure.
  • Inflammation control: Inflammatory cytokines (CRP, IL-6, TNF-α) decrease significantly over a course of HBOT, creating a more receptive uterine environment.
  • Stem cell mobilization: HBOT mobilizes CD34+ stem cells up to 8x baseline, supporting tissue repair and ovarian reserve potential. [PMC, 2023]

How HBOT Improves IVF Outcomes

Clinical research increasingly supports HBOT as a meaningful adjunct to IVF, particularly for patients who have experienced failed cycles or suboptimal implantation conditions.

A key study published in the Journal of Assisted Reproduction and Genetics demonstrated that 10 sessions of HBOT before embryo transfer significantly improved endometrial thickness, uterine blood flow, and implantation rates in patients with previously resistant thin endometrium. [PubMed, 2023]

A 2025 Frontiers in Reproductive Health review identified endometrial hypoperfusion — inadequate blood flow to the uterine lining — as the primary driver of treatment-resistant thin endometrium, and positioned HBOT as one of the most promising interventions to correct it. [Frontiers in Reproductive Health, 2025]

At OxygenWell, the IVF preparation protocol begins 6–8 weeks before the planned embryo transfer date, with sessions running 3–5 times per week at 1.5–2.0 ATA for 60–90 minutes. Patients who complete the full pre-transfer protocol report improvements in endometrial thickness confirmed on ultrasound, improved uterine perfusion, and reductions in inflammatory markers.

Can HBOT Help a Thin Endometrium?

A thin endometrium — typically defined as less than 7mm — is one of the most frustrating diagnoses in reproductive medicine. Standard interventions including estrogen supplementation and intrauterine infusions fail a significant proportion of patients. For these women, HBOT offers a fundamentally different mechanism: addressing the root cause of inadequate lining development rather than adding more estrogen.

The mechanism is direct. Poor endometrial development is almost always driven by inadequate blood flow and oxygenation to the uterine lining. HBOT corrects this by:

  • Stimulating new capillary growth (angiogenesis) into the endometrial tissue
  • Increasing oxygen tension in hypoperfused uterine tissue
  • Reducing inflammatory signals that inhibit endometrial proliferation
  • Supporting tissue regeneration at the cellular level

The recommended protocol for thin endometrium at OxygenWell is 15–30 sessions, ideally daily or near-daily, timed to the early follicular phase of the menstrual cycle before transfer.

Does HBOT Improve Egg Quality?

Egg quality is fundamentally a mitochondrial problem. Mature oocytes require enormous amounts of cellular energy (ATP) to complete meiosis, fertilize, and develop into a viable embryo. As ovarian reserve declines and oxidative stress accumulates with age, mitochondrial function in eggs deteriorates — producing the poor fertilization rates and high miscarriage risk associated with diminished ovarian reserve (DOR).

HBOT directly targets both drivers. Elevated oxygen pressure restores mitochondrial ATP production in metabolically depleted cells, while simultaneous activation of endogenous antioxidants clears the oxidative damage that disrupts oocyte maturation.

Published data from Reproductive BioMedicine Online demonstrates that HBOT improves oocyte yield and embryo quality in patients with poor ovarian response. [PMC, 2025]

The OxygenWell protocol for poor egg quality and diminished ovarian reserve: 20–40 sessions, cycle-based or pre-IVF, at 1.5–2.0 ATA for 60–90 minutes.

HBOT for Male Fertility and Sperm Health

Infertility is a shared challenge. Male factor infertility contributes to up to 50% of all cases, yet men are frequently undertreated in the fertility workup. HBOT addresses the cellular root causes of poor sperm quality directly.

The testes are highly oxygen-dependent tissue. Sperm DNA fragmentation — a leading cause of failed fertilization and recurrent pregnancy loss — increases significantly under conditions of oxidative stress and poor testicular circulation. HBOT corrects both simultaneously:

  • Improves testicular oxygenation and microcirculation
  • Reduces sperm DNA fragmentation through antioxidant activation
  • Improves sperm count, motility, and morphology
  • Reduces systemic inflammation that impairs hormonal signaling

Published research in Frontiers in Physiology (2021) confirms HBOT's beneficial effect on sperm parameters in men with documented fertility challenges. The OxygenWell male fertility protocol runs 20–30 sessions, daily or near-daily.

HBOT for Specific Fertility Conditions

Endometriosis

Endometriosis creates a chronic inflammatory environment in the pelvis that directly impairs implantation, damages egg quality, and disrupts the hormonal signaling required for conception. HBOT reduces inflammatory cytokines, improves pelvic circulation, and supports tissue healing — addressing the inflammatory terrain that makes conception difficult. Protocol: 20–40 sessions, daily or near-daily.

Recurrent Pregnancy Loss

Recurrent implantation failure and early pregnancy loss are often driven by endometrial environment deficiencies, immune dysregulation, and poor placental vascularization. HBOT improves endometrial blood flow and immune balance, creating a more stable environment for early embryo development and placental formation.

HPO Axis and Hormonal Dysregulation

The hypothalamic-pituitary-ovarian (HPO) axis orchestrates the hormonal cascade required for ovulation, implantation, and pregnancy. HBOT improves oxygenation to the hypothalamus and pituitary, supports adrenal function, reduces cortisol interference with reproductive hormones, and enhances insulin sensitivity — all of which support more balanced hormonal signaling. Protocol: 15–30 sessions, daily or once weekly maintenance.

How Many HBOT Sessions Do You Need Before IVF?

The right protocol depends on the specific fertility challenge and where you are in your treatment cycle. OxygenWell uses three primary protocol structures:

Phase | Goal | Frequency | Sessions | Pressure

Foundational Reset | Reduce inflammation, improve baseline oxygenation | 2–3x/week | 4–8 weeks | 1.5–2.0 ATA

IVF Pre-Transfer Optimization | Thicken lining, optimize implantation environment | 3–5x/week | 10–20 sessions | 1.5–2.0 ATA

Ongoing Maintenance | Sustain gains, support hormonal balance | 1–2x/week | Ongoing | 1.3–1.5 ATA

For most IVF patients, the pre-transfer protocol begins 6–8 weeks before the planned transfer date and finishes 3–5 days before transfer. Sessions run 60–90 minutes each and are comfortable enough to complete before or after a normal workday.

Is HBOT Safe During a Fertility Treatment Cycle?

HBOT is a non-invasive, drug-free therapy. It introduces no hormones, no pharmaceutical agents, and no procedures into the body. The treatment is pregnancy-safe with appropriate clearance and is compatible with natural conception cycles, IUI, and IVF.

OxygenWell uses FDA-cleared monoplace chambers at medical-grade pressures (up to 2.4 ATA) with 100% medical-grade oxygen — not oxygen concentrators. All sessions are supervised by Certified Hyperbaric Technicians (CHTs), most of whom are EMT-certified, with a Physician Assistant on-site during most weekday hours.

A full intake evaluation and medical clearance precedes every fertility protocol. Patients with specific medical conditions are reviewed individually before treatment begins.

Fertility HBOT in Los Angeles: OxygenWell

OxygenWell is Los Angeles's leading integrative hyperbaric medicine center, with 12+ years of experience and 50,000+ supervised HBOT sessions across Sherman Oaks and Calabasas.

What sets OxygenWell apart from other HBOT centers in Los Angeles is the depth of clinical expertise behind every fertility protocol. OxygenWell's Wellness Director and Co-Founder, Dr. Beth Meneley, DAOM, L.Ac., brings over 20 years of specialized focus on fertility — including founding Tao of Venus Acupuncture Center and developing The Functional Fertility Method, a pioneering approach that integrates functional medicine and Chinese medicine for both male and female fertility challenges. She is one of the few HBOT practitioners in Southern California who understands fertility at a clinical and cellular level.

Her approach at OxygenWell is not simply to add HBOT to a standard protocol. It is to assess each patient's underlying reproductive terrain — oxygenation, inflammation, hormonal signaling, oxidative stress, and mitochondrial function — and design a protocol that addresses root causes, not just symptoms.

The Fertility Optimization Protocol at OxygenWell is designed for:

  • Women preparing for IVF or frozen embryo transfer
  • Patients with thin endometrium or implantation failure
  • Women with diminished ovarian reserve or poor egg quality
  • Men with poor sperm parameters or DNA fragmentation
  • Couples pursuing natural conception who want to optimize their reproductive environment
  • Women with endometriosis, PCOS, or recurrent pregnancy loss

OxygenWell accepts Medicare and PPO insurance for FDA-approved indications and offers self-pay packages for fertility optimization protocols. Both locations offer extended hours including evenings and weekends.

Call (818) 661-0939 or visit oxygenwell.com to schedule a free discovery call and discuss whether HBOT is right for your fertility journey.

HBOT is a supportive, adjunct therapy and is not a replacement for care provided by your reproductive endocrinologist or fertility specialist. OxygenWell works collaboratively with your existing care team.

Related Post
Refer a Patient — Hyperbaric Oxygen Therapy Los Angeles
Refer a Patient — Hyperbaric Oxygen Therapy Los Angeles
July 11, 2026